|
|
National Stock Number: 6505-00-584-3131
Federal Supply Class: 6505
National Item Identification Number: 005843131
Description: LIDOCAINE HYDROCHLORIDE JELLY
|
Manufacturer Information:
NDC00093-9200-31 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. | NDC00186-0330-01 | 00E55 | CARDINAL HEALTH, INC. | NDC00186-0330-01 | 04473 | ASTRA PHARMACEUTICALS LP | NDC00186-0330-01 | 0A423 | CARDINAL HEALTH 100 INC DBA BINDLEY WESTERN TENNESSEE DIV | NDC00186-0330-01 | 1DQP2 | AMERICAN PHARMACEUTICAL PARTNERS | NDC00591-3012-30 | 56287 | ACTAVIS ELIZABETH LLC | XYL0CAINE | 04473 | ASTRA PHARMACEUTICALS LP | XYLOCAINE | 04473 | ASTRA PHARMACEUTICALS LP | NDC63323-0479-30 | 4JRB5 | APP PHARMACEUTICALS INC. | NDC17478-0711-30 | 55751 | AKORN, INC. | NDC63323-0479-30 | 57KZ6 | FRESENIUS KABI, LLC | NDC17478-0711-30 | 60061 | AKORN INC |
|
Techincal Specification:
ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT AND 3.500 PERCENTAGE, W/V CARBOXYMETHYLCELLULOSE SODIUM ACTIVE INGREDIENT | FEATURES PROVIDED | STERILE | PART NAME ASSIGNED BY CONTROLLING AGENCY | LIDOCAINE HYDROCHLORIDE JELLY USP 2% 30 ML TUBE WITH APPLICATOR | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA | SPECIAL FEATURES | APPLICATOR INCLUDED; ADMINISTERED TOPICALLY, NOT FOR OPHTHALMIC USE. STOORE AT USP CONTROLLED ROOM TEMPERATURE 20 TO 25 C (68 TO 77 F. | PRIMARY CONTAINER CONTENT QUANTITY | 30.000 MILLILITERS | PRIMARY CONTAINER TYPE | TUBE, COLLAPSIBLE |
|
|